Looming Respiratory Virus Season Fuels Widespread Concern Among Healthcare Professionals
A recent global survey of healthcare providers reveals a significant level of apprehension regarding the upcoming fall and winter respiratory virus season. With the anticipated convergence of influenza, respiratory syncytial virus (RSV), and COVID-19, 95% of the 607 surveyed clinicians expressed concern about the potential impact. The Sermo Real Time Barometer survey, conducted in August 2025, captured the perspectives of physicians across various specialties, advanced practice providers (APPs), and pharmacists, providing a comprehensive overview of the challenges facing the healthcare community. The pervasive issue of misinformation surrounding vaccines emerged as a dominant theme, with nearly 90% of respondents reporting a moderate to significant impact on their practice.
The Persistent Challenge of Vaccine Misinformation
Healthcare professionals identified vaccine misinformation as the primary obstacle to patient acceptance of vaccinations. Concerns about vaccine safety and the perceived lack of necessity were cited as the most common reasons for vaccine hesitancy. To combat this, clinicians are increasingly prioritizing direct patient education, engaging in conversations about vaccine benefits and risks during consultations. Many are also providing printed resources and directing patients to reliable online sources of information. The importance of building trust and addressing individual concerns was emphasized, with clinicians advocating for a personalized approach to vaccine counseling.
Vaccine Uptake Predictions for the Upcoming Season
Survey results indicate that influenza is expected to be the predominant respiratory illness this year, with 77% of clinicians, and a striking 90% of nurse practitioners, planning to actively promote flu vaccination. However, projections for other respiratory vaccines remain less optimistic. While 72% of clinicians anticipate high flu vaccine uptake, expectations for COVID-19 boosters and RSV vaccines are more tempered. Only 36% foresee majority uptake for COVID-19 boosters, while 37% predict strong uptake for the adult RSV vaccine, despite the significant hospitalization risks for older adults. Pediatric RSV vaccine uptake is projected to be higher, at 51%, with 86% of pediatricians planning to increase their advocacy efforts. For pneumococcal vaccines, roughly half of the respondents predict majority uptake in both adult and pediatric populations.
Pharmacists Emerge as Frontline Respiratory Care Providers
The survey highlighted the evolving role of retail pharmacists in respiratory care. With increasing frequency, patients are turning to pharmacists as their initial point of contact for respiratory symptom management. This trend is reflected in the survey findings, with 58% of clinicians reporting that patients are increasingly seeking advice from pharmacists before consulting other healthcare professionals. Pharmacists are now often the first line of defense, providing readily accessible advice, performing rapid diagnostic tests for influenza and strep throat, and promoting preventative vaccinations. This shift in healthcare dynamics underscores the importance of collaboration between pharmacists and other healthcare providers to ensure optimal patient care.
Navigating Evolving Guidelines and Environmental Challenges
Clinicians also face challenges related to updated treatment guidelines and the impact of environmental factors on respiratory health. While over a third of respondents acknowledged the influence of new guidelines on their clinical decision-making, patient non-compliance remains a significant hurdle. The vast majority of clinicians (96%) emphasized the critical need for real-time respiratory surveillance data, even as government reporting on COVID-19 and influenza diminishes. The growing impact of climate change on respiratory illness was also recognized, with 77% of respondents identifying it as a contributing factor. Air pollution and rising allergen levels were cited as the primary climate-related concerns, and a staggering 83% believe that these environmental factors will substantially increase respiratory illness cases within the next five years.
The Path Forward: Collaboration, Education, and Adaptation
The survey findings paint a clear picture of the challenges and opportunities facing the healthcare community in the upcoming respiratory virus season. Combating misinformation, promoting vaccination, and adapting to the evolving role of pharmacists will be crucial for effectively managing the anticipated surge in respiratory illnesses. Continued emphasis on patient education, collaborative care models, and real-time surveillance data will be essential for mitigating the impact of these viruses on individuals and the healthcare system as a whole. Furthermore, addressing the long-term implications of climate change on respiratory health will require a concerted effort from healthcare providers, policymakers, and the public alike.
